New study tests if blood markers can spot baby distress in real time

NCT ID NCT07258329

Recruiting now Knowledge-focused Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at whether certain substances from the placenta (called sFlt-1 and PlGF) can help doctors know if a baby is in trouble during labor. Researchers will check these markers in pregnant women and compare them to the baby's heart rate and health after birth. The goal is to see if a simple blood test could improve how we monitor labor and prevent harm to newborns.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a new screening method to detect fetal distress during labor earlier, potentially reducing birth complications.
What could go wrong: This is an observational study, not a treatment trial. It only looks for associations, so it may not directly change care. Results may not apply to all pregnancies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREGNANT WOMEN

Contacts and locations

Locations

IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITING

Bologna, Bologna, 40138, Italy
IRCCS Ca' Granda Ospedale Maggiore Policlinico
NOT_YET_RECRUITING

Milan, Milano, 20122, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.